Hikma Pharma shares rise on 'unsolicited enquiries'

1st Mar 2013 11:42

Hikma Pharmaceuticals on Friday confirmed that it has received several unsolicited enquiries in its Injectables business and is now undertaking a review of strategic options for its future. In a statment the group's Chief Executive Officer said: "We have received a number of unsolicited expressions of interest in our Injectables business and will consider the best option for shareholders."The share price rose 4.85% to 908p by 12:05.NR

Top Risers

Share	Price	Change
Parkmead (PMG)	12.25	0%
Cloudcoco (CLCO)	0.325	0%
Microsalt (SALT)	75.00	0%
Chariot (CHAR)	2.60	0%
Bushveld Minerals (BMN)	0.375	0%

Top Fallers

Share	Price	Change
Armadale Capital (ACP)	0.075	0%
Proton Mtr Pwr (PPS)	0.75	0%
Alien Metals (UFO)	0.115	0%
Nexteq (NXQ)	74.00	0%
Biome Tech (BIOM)	5.75	0%

Top By Volume

Share	Price	Volume
Nativo Resources (NTVO)	0.0025	0
Inspirit Energy (INSP)	0.0032	0
Tower Resources (TRP)	0.0305	0
UK Oil & Gas (UKOG)	0.0375	0
Mosman Oil Gas (MSMN)	0.038	0

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.